Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
not assigned
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
Serodus ASA
|
| gptkbp:intendedUse |
treatment of diabetic nephropathy
|
| gptkbp:mechanismOfAction |
selective serotonin 5-HT2A receptor antagonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:bfsParent |
gptkb:Seres_Therapeutics
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
SER-155
|